|

A Prospective, Multicenter Registry to Observe the Treatment Patterns, Clinical Outcomes, and Decision-Making in Patients With Early Breast Cancer Eligible for EndoPredict® Testing

RECRUITINGSponsored by National and Kapodistrian University of Athens
Actively Recruiting
SponsorNational and Kapodistrian University of Athens
Started2025-04-01
Est. completion2028-03-31
Eligibility
Age18 Years+
Healthy vol.Accepted
View on ClinicalTrials.gov →

NCT07389408

Summary

The study is planned to observe and document the therapeutic decision-making process, treatment protocols, and clinical outcomes in patients with luminal breast cancer, whether they have undergone EndoPredict® testing or not

Eligibility

Age: 18 Years+Healthy volunteers accepted
Inclusion Criteria:

* Age ≥ 18 years old.
* Histological diagnosis of invasive breast cancer.
* T1-T3 tumor size.
* 0-3 positive axillary lymph nodes.
* Documented ER-positive tumor by immunohistochemistry (≥1% or Allred Score: ≥3/8 or H-score: ≥50/ 300)
* Documented HER2-negative tumor by immunohistochemistry and/or in situ hybridization
* Subject with signed and dated informed consent form.

Exclusion Criteria:

* History of another primary malignancy within the last 5 years, except for resected non-melanoma skin cancer.
* Pre-operative chemotherapy administered.
* Subject without signed and dated informed consent form.

Conditions3

Breast AdenocarcinomaBreast CancerCancer

Browse More Trials

Cancer trialsBreast Cancer trials

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.